Supporting Emergency Medical Education, PT Djembatan Dua Participates in PBPK 2025

PT Djembatan Dua a subsidiary of PT Medela Potentia Tbk continues to demonstrate its dedication to advancing laboratory services by actively participating in the 23rd Continuing Education Program in Clinical Pathology (PBPK XXIII). The event, organized by the Indonesian Association of Clinical Pathology and Laboratory Medicine Specialists (PDS Patklin) Jakarta, took place on August 22–24, 2025, at the Raffles Hotel, Jakarta.

Carrying the theme “Laboratory Insight in Emergency Care: Bridging Promptness and Precision”, PBPK XXIII provided an important platform for clinical pathology specialists and healthcare professionals to expand their expertise. The theme emphasized the critical contribution of laboratories in emergency medicine, where speed and accuracy of diagnostic results directly influence clinical decisions and patient outcomes.

As part of its participation, PT Djembatan Dua introduced a lineup of innovative medical devices designed to support laboratory performance in emergency cases. Among the featured solutions were Tubex TF, Quidel Triage, Labchoice DecaBio, Labchoice Drug Abuse Test, Vigeo Biopsy, and safety lancets—all representing the company’s commitment to delivering technology-driven, practical solutions for healthcare providers.

“By joining PBPK XXIII, PT Djembatan Dua reinforces its long-standing commitment to empowering laboratories and medical professionals. We believe laboratories serve as a frontline in saving lives, where timely and precise diagnostics are essential,” stated Mrs. Ariance Margaretha, Business Manager of PT Djembatan Dua.

The three-day event brought together hundreds of participants, including clinical pathology specialists, physicians from various fields, general practitioners, and Medical Laboratory Technologists (ATLM). Beyond knowledge sharing, PBPK XXIII strengthened interdisciplinary collaboration, enabling professionals to work more effectively in delivering quality healthcare services.

Through its involvement, PT Djembatan Dua aims not only to enhance laboratory capacity across Indonesia but also to play an active role in ensuring that healthcare delivery becomes more responsive, accurate, and impactful for patients.